Lytix Biopharma AS (OSL:LYTIX)

Norway · Delayed Price · Currency is NOK

5.70

+0.10 (1.79%)

May 13, 2025, 4:29 PM CET

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Oncolytic Peptides	3.99M	Log In
Oncolytic Peptides Growth	-76.89%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	3.99M	Log In
United States Growth	-63.82%	Log In
Norway	-	Log In